Search
for
Sort by
Research 31–60 of 1000+
- Low Anabolic Profile in Assessing a Patients Overall Hair Loss
- Effect of a low insulinemic diet on clinical, biochemical and metabolic outcomes in women with polycystic ovary syndrome (PCOS)
- Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats
- The effect of platelet-derived growth factor-aa (PDGFA) conjugated with low-molecular-weight protamine (LMWP) on hair loss improvement effect
- Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- EFFECTS OF A LOW‐DOSE DESOGESTREL‐ETHINYLESTRADIOL COMBINATION ON HIRSUTISM, ANDROGENS AND SEX HORMONE BINDING GLOBULIN IN WOMEN WITH A POLYCYSTIC OVARY SYNDROME
- Oral administration of low-dose bisphenol A promotes proliferation of ventral prostate and upregulates prostaglandin D<sub>2</sub> synthase expression in adult rats
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Overcoming the Low Bioavailability of Apigenin: The Therapeutic Efficacy for Androgenetic Alopecia Through Topical Administration
- Clinical Evaluation of Women Presenting with Low Libido and Determination of Whether Androgen Therapy Might Be Appropriate
- Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients
- Female pattern hair loss may be triggered by low oestrogen to androgen ratio.
- Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels
- Disorders of sex development (DSD) 46.XY due to type 2 5-α reductase deficiency in three siblings: Case report from a low-resource setting
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- Detection of Male Hypogonadism in Patients with Post COVID-19 Condition
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- A Perspective on the Evolving Landscape in Male Reproductive Medicine
- Therapeutic Androgen Receptor Ligands
- The role of androgens in hormone replacement therapy
- Introduction to: Endocrinological aspects of andrology—what is new?
- SAT-148 Late Diagnosis of Klinefelter Syndrome: Overcoming Phenotypic Variability and Diagnostic Oversights
- An Adult With Hair Loss! a Rare Case of Non-Classical 3β Hydroxysteroid Dehydrogenase (3β HSD) Deficiency
- 37-Year-Old Man With Fatigue and Erectile Dysfunction
- Women Also Use 5α-Reductase Inhibitors